In late 2025, Hyperscale Data, Inc. filed a shelf registration to potentially issue 43,011,836 shares of Class A common stock, with a maximum aggregate offering size of US$8.60 million. This filing ...
Altimmune recently announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to pemvidutide, its balanced 1:1 glucagon/GLP-1 dual agonist, for treating metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback